{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:18:17Z","timestamp":1762507097969},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T00:00:00Z","timestamp":1496620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00280-017-3347-0","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T14:41:42Z","timestamp":1496673702000},"page":"177-185","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"80","author":[{"given":"Nasrin","family":"Dehghan-Nayeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Eshghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourosh Goudarzi","family":"Pour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Davood","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Gharehbaghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,5]]},"reference":[{"issue":"11","key":"3347_CR1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba H, Pui CH (2010) Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 11(11):1096\u20131106","journal-title":"Lancet Oncol"},{"issue":"2","key":"3347_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcp.1040980203","volume":"98","author":"JM Harmon","year":"1979","unstructured":"Harmon JM, Norman MR, Fowlkes BJ, Thompson EB (1979) Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol 98(2):267\u2013278","journal-title":"J Cell Physiol"},{"key":"3347_CR3","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1200\/JCO.2001.19.12.3066","volume":"19","author":"AJ Strauss","year":"2001","unstructured":"Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB (2001) Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19:3066\u20133072","journal-title":"J Clin Oncol"},{"issue":"2","key":"3347_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/leu.2009.262","volume":"24","author":"PS Gaynon","year":"2010","unstructured":"Gaynon PS, Angiolillo AL, Carroll WL et al (2010) Long-term results of the children\u2019s cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children\u2019s Oncology Group Report. Leukemia 24(2):285\u2013297","journal-title":"Leukemia"},{"issue":"6","key":"3347_CR5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"C-H Pui","year":"2012","unstructured":"Pui C-H, Mullighan CG, Evans WE, Relling MV (2012) Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 120(6):1165\u20131174","journal-title":"Blood"},{"issue":"1","key":"3347_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","volume":"62","author":"SL Cooper","year":"2015","unstructured":"Cooper SL, Brown PA (2015) Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin N Am 62(1):61\u201373","journal-title":"Pediatr Clin N Am"},{"issue":"3 Suppl 1","key":"3347_CR7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.metabol.2014.10.027","volume":"64","author":"M Kalia","year":"2015","unstructured":"Kalia M (2015) Biomarkers for personalized oncology: recent advances and future challenges. Metabolism 64(3 Suppl 1):S16\u2013S21","journal-title":"Metabolism"},{"key":"3347_CR8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/clpt.2014.153","volume":"96","author":"L Minasian","year":"2014","unstructured":"Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky RL (2014) Optimizing dosing of oncology drugs. Clin Pharmacol Ther 96:572\u2013579","journal-title":"Clin Pharmacol Ther"},{"issue":"32","key":"3347_CR9","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2015.61.5997","volume":"33","author":"M Schwaederle","year":"2015","unstructured":"Schwaederle M, Zhao M, Lee JJ (2015) Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials. J Clin Oncol 33(32):3817\u20133825","journal-title":"J Clin Oncol"},{"issue":"7","key":"3347_CR10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jcmm.12319","volume":"18","author":"E L\u00f3pez Villar","year":"2014","unstructured":"L\u00f3pez Villar E, Wu D, Cho WC, Madero L, Wang X (2014) Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities. J Cell Mol Med 18(7):1239\u20131246","journal-title":"J Cell Mol Med"},{"key":"3347_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-016-0357-3","author":"N Dehghan-Nayeri","year":"2016","unstructured":"Dehghan-Nayeri N, Rezaei-Tavirani M, Omrani MD, Gharehbaghian A, Goudarzi Pour K, Eshghi P (2016) Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia. J Cell Commun Signal. doi: 10.1007\/s12079-016-0357-3","journal-title":"J Cell Commun Signal"},{"key":"3347_CR12","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3347_CR13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ncb3215","volume":"17","author":"N Mi","year":"2015","unstructured":"Mi N, Chen Y, Wang S et al (2015) CapZ regulates autophagosomal membrane shaping by promoting actin assembly inside the isolation membrane. Nat Cell Biol 17(9):1112\u20131123","journal-title":"Nat Cell Biol"},{"issue":"4","key":"3347_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CMR.0b013e328346b715","volume":"21","author":"D Sun","year":"2011","unstructured":"Sun D, Zhou M, Kowolik CM et al (2011) Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma. Melanoma Res 21(4):335\u2013343","journal-title":"Melanoma Res"},{"key":"3347_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1937-6448(08)00604-7","volume":"267","author":"JA Cooper","year":"2008","unstructured":"Cooper JA, Sept D (2008) New insights into mechanism and regulation of actin capping protein. Int Rev Cell Mol Biol 267:183\u2013206","journal-title":"Int Rev Cell Mol Biol"},{"key":"3347_CR16","doi-asserted-by":"publisher","unstructured":"Feng S, Lin S, Zou J, Wang Y, Ji Q, Lv Z (2015) Association between rs12045440 polymorphism in the CAPZB intron and serum TSH concentrations in Chinese thyroid tumor patients. Int J Endocrinol 2015. doi: 10.1155\/2015\/250542","DOI":"10.1155\/2015\/250542"},{"issue":"5","key":"3347_CR17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3892\/ijo.2013.1867","volume":"42","author":"Y-J Lee","year":"2013","unstructured":"Lee Y-J, Jeong S-H, Hong S-C et al (2013) Prognostic value of CAPZA1 overexpression in gastric cancer. Int J Oncol 42(5):1569\u20131577","journal-title":"Int J Oncol"},{"issue":"1","key":"3347_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/gut.2005.083691","volume":"56","author":"CC Thompson","year":"2007","unstructured":"Thompson CC, Ashcroft FJ, Patel S et al (2007) Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56(1):95\u2013106","journal-title":"Gut"},{"key":"3347_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-9966-31-44","volume":"31","author":"L Wang","year":"2012","unstructured":"Wang L, He S, Tu Y et al (2012) Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas. J Exp Clin Cancer Res 31:44","journal-title":"J Exp Clin Cancer Res"},{"key":"3347_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2040-2384-2-23","volume":"2","author":"JJ Tung","year":"2010","unstructured":"Tung JJ, Kitajewski J (2010) Chloride intracellular channel 1 functions in endothelial cell growth and migration. J Angiogenes Res 2:23","journal-title":"J Angiogenes Res"},{"issue":"10 Pt B","key":"3347_CR21","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.bbamem.2014.12.012","volume":"1848","author":"M Peretti","year":"2015","unstructured":"Peretti M, Angelini M, Savalli N, Florio T, Yuspa SH, Mazzanti M (2015) Chloride channels in cancer: focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets. Biochim Biophys Acta 1848(10 Pt B):2523\u20132531","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"3347_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/cbr.2014.1666","volume":"29","author":"Y Tian","year":"2014","unstructured":"Tian Y, Guan Y, Jia Y, Meng Q, Yang J (2014) Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK\/ERK pathway. Cancer Biother Radiopharm 29(8):339\u2013344","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"3347_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13277-014-2606-5","volume":"36","author":"Q Ding","year":"2015","unstructured":"Ding Q, Li M, Wu X et al (2015) CLIC1 overexpression is associated with poor prognosis in gallbladder cancer. Tumour Biol 36(1):193\u2013198","journal-title":"Tumour Biol"},{"issue":"1\u20132","key":"3347_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11010-012-1271-5","volume":"365","author":"P Wang","year":"2012","unstructured":"Wang P, Zhang C, Yu P et al (2012) Regulation of colon cancer cell migration and invasion by CLIC1-mediated RVD. Mol Cell Biochem 365(1\u20132):313\u2013321","journal-title":"Mol Cell Biochem"},{"issue":"24","key":"3347_CR25","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3748\/wjg.v18.i24.3070","volume":"18","author":"PF Ma","year":"2012","unstructured":"Ma PF, Chen JQ, Wang Z, Liu JL, Li BP (2012) Function of chloride intracellular channel 1 in gastric cancer cells. World J Gastroenterol 18(24):3070\u20133080","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3347_CR26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13277-011-0223-0","volume":"32","author":"W Wang","year":"2011","unstructured":"Wang W, Xu X, Wang W et al (2011) The expression and clinical significance of CLIC1 and HSP27 in lung adenocarcinoma. Tumour Biol 32(10):1199\u20131208","journal-title":"Tumour Biol"},{"issue":"1009\u20131010","key":"3347_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jchromb.2015.12.012","volume":"15","author":"P Giuliani","year":"2016","unstructured":"Giuliani P, Zuccarini M, Buccella S et al (2016) Development of a new HPLC method using fluorescence detection without derivatization for determining purine nucleoside phosphorylase activity in human plasma. J Chromatogr B 15(1009\u20131010):114\u2013121","journal-title":"J Chromatogr B"},{"key":"3347_CR28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood-2010-02-272039","volume":"116","author":"K Balakrishnan","year":"2010","unstructured":"Balakrishnan K, Verma D, O\u2019Brien S et al (2010) Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia. Blood 116:886\u2013892","journal-title":"Blood"},{"issue":"2","key":"3347_CR29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/bjc.2011.462","volume":"106","author":"S Kojima","year":"2012","unstructured":"Kojima S, Chiyomaru T, Kawakami K et al (2012) Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 106(2):405\u2013413","journal-title":"Br J Cancer"},{"issue":"6","key":"3347_CR30","first-page":"1821","volume":"40","author":"T Yamasaki","year":"2012","unstructured":"Yamasaki T, Yoshino H, Enokida H et al (2012) Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol 40(6):1821\u20131830","journal-title":"Int J Oncol"},{"issue":"1","key":"3347_CR31","first-page":"57","volume":"14","author":"O Sanfilippo","year":"1994","unstructured":"Sanfilippo O, Camici M, Tozzi MG et al (1994) Relationship between the levels of purine salvage pathway enzymes and clinical\/biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 14(1):57\u201366","journal-title":"Cancer Biochem Biophys"},{"issue":"6","key":"3347_CR32","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/pr500352e","volume":"13","author":"MP Pavlou","year":"2014","unstructured":"Pavlou MP, Dimitromanolakis A, Martinez-Morillo E, Smid M, Foekens JA, Diamandis EP (2014) Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer. J Proteome Res 13(6):2897\u20132909","journal-title":"J Proteome Res"},{"issue":"3","key":"3347_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1590\/S0100-879X2012007500026","volume":"45","author":"L Zhang","year":"2012","unstructured":"Zhang L, Hou Y, Wu K, Li D (2012) Comparative proteomics analysis of chronic atrophic gastritis: changes of protein expression in chronic atrophic gastritis without Helicobacter pylori infection. Braz J Med Biol Res 45(3):273\u2013283","journal-title":"Braz J Med Biol Res"},{"key":"3347_CR34","first-page":"577","volume":"31","author":"D Zhang","year":"2007","unstructured":"Zhang D, Lim SG, Koay ES (2007) Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol 31:577\u2013584","journal-title":"Int J Oncol"},{"key":"3347_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1440-1746.2003.02921.x","volume":"18","author":"T Miyagi","year":"2003","unstructured":"Miyagi T, Tatsumi T, Takehara T et al (2003) Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells. J Gastroenterol Hepatol 18:32\u201340","journal-title":"J Gastroenterol Hepatol"},{"key":"3347_CR36","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1021\/pr0702722","volume":"6","author":"R Lemaire","year":"2007","unstructured":"Lemaire R, Menguellet SA, Stauber J et al (2007) Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment is a new potential ovary cancer biomarker. J Proteome Res 6:4127\u20134134","journal-title":"J Proteome Res"},{"issue":"6","key":"3347_CR37","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1021\/pr200141c","volume":"10","author":"J Zhang","year":"2011","unstructured":"Zhang J, Wang K, Zhang J, Liu SS, Dai L, Zhang JY (2011) Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res 10(6):2863\u20132872","journal-title":"J Proteome Res"},{"issue":"34","key":"3347_CR38","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1073\/pnas.1300013110","volume":"110","author":"D S\u00e1nchez-Mart\u00edn","year":"2013","unstructured":"S\u00e1nchez-Mart\u00edn D, Mart\u00ednez-Torrecuadrada J, Teesalu T et al (2013) Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci USA 110(34):13791\u201313796","journal-title":"Proc Natl Acad Sci USA"},{"issue":"111","key":"3347_CR39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2014.04.019","volume":"5","author":"MA Mu\u00f1iz Lino","year":"2014","unstructured":"Mu\u00f1iz Lino MA, Palacios-Rodr\u00edguez Y, Rodr\u00edguez-Cuevas S et al (2014) Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. J Proteomics 5(111):198\u2013211","journal-title":"J Proteomics"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3347-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T16:39:59Z","timestamp":1569429599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3347-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,5]]}}}